Biodiversity as a Source of Potent and Selective Inhibitors of Chikungunya Virus Replication

Novel Plant Bioresources: Applications in Food, Medicine and Cosmetics

Volumn 9781118460610, Issue , 2014, Pages 151-161

  Leyssen, Pieter ^a   Smadja, Jacqueline ^b   Rasoanaivo, Philippe ^c   Gurib Fakim, Ameenah ^d   Mahomoodally, Mohamad Fawzi ^e   Canard, Bruno ^f   Guillemot, Jean Claude ^f   Litaudon, Marc ^g   Guéritte, Françoise ^g  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITÉ DE LA RÉUNION   (France)

^c INSTITUT MALGACHE DE RECHERCHES APPLIQUÉES   (Madagascar)

^d Center for Phytotherapy Research (CEPHYR)   (Mauritius)

^e UNIVERSITY OF MAURITIUS   (Mauritius)

^f Centre National de la Recherche Scientifique   (France)

^g CNRS   (France)

Author keywords

Antiviral agents; Chikungunya; Indian Ocean; Secondary metabolites

Indexed keywords

ANTIVIRAL AGENTS; BIODIVERSITY; DISEASE CONTROL; DISEASES; METABOLITES; OCEANOGRAPHY; TROPICS;

ANTI-VIRAL DRUGS; CHIKUNGUNYA; INDIAN OCEAN; PATHOGENIC VIRUS; POTENT INHIBITOR; RESEARCH PROGRAMS; SECONDARY METABOLITES; SELECTIVE INHIBITORS; TROPICAL DISEASE; VIRUS REPLICATION;

VIRUSES;

EID: 84927161675     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118460566.ch11     Document Type: Chapter

References (43)

1. Allard, P.M., Leyssen, P., Martin, M.T. et al. (2012a) Antiviral chlorinated daphnane diterpenoid orthoesters from the bark and wood of Trigonostemon cherrieri. Phytochemistry, 84, 160-168.
2. Allard, P.M., Martin, M.T., Tran Huudau, M.E. et al. (2012b) Trigocherrin A, the first natural chlorinated daphnane diterpene orthoester from Trigonostemon cherrieri. Organic Letters, 14 (1), 342-345.
3. Bassetto, M., de Burghgraeve, T., Leyssen, P. et al. (2011) Computeraided design and evaluation of novel anti-CHIKV compounds. Antiviral Research, 90 (2), A67.
4. Bora, L. (2012) Homology modeling and docking to potential novel inhibitor for chikungunya (37997) protein nsP2 protease. Journal of Proteomics & Bioinformatics, 5 (2), 054-059.
5. Boriskin, Y.S., Leneva, I.A., Pécheur, E.I., and Polyak, S.J. (2008) Arbidol: a broad-spectrum antiviral compound that blocks viral fusion. Current Medicinal Chemistry, 15, 997-1005.
6. Bourjot, M., Delang, L., Nguyen, V.H. et al. (2012a) Prostratin and 12-O-tetradecanoylphorbol 13-acetate are potent and selective inhibitors of chikungunya virus replication. Journal of Natural Products, 75, 2183-2187.
7. Bourjot, M., Delmotte, S., Leyssen, P. et al. (2012b) Flacourtosides A-F, phenolic glycosides isolated from Flacourtia ramontchi, potential inhibitors of emerging viruses. Journal of Natural Products, 75, 752-758.
8. Bourjot, M., Leyssen, P., Eydoux, C. et al. (2012c) Chemical constituents of Anacolosa pervilleana and their antiviral activities. Fitoterapia, 83 (6), 1076-1080.
9. Briolant, S., Garin, D., Scaramozzino, N. et al. (2004) In vitro inhibition of chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-α and ribavirin combination. Antiviral Research, 61 (2), 111-117.
10. Clardy, J., and Walsh, C. (2004) Lessons from natural molecules. Nature, 432, 829-837.
11. Cos, P., Vlietinck, A.J., Vanden Berghe, D., and Maes, L. (2006) Anti-infective potential of natural products: how to develop a stronger in vitro "proof-of-concept". Journal of Ethnopharmacology, 106, 290-302.
12. De Lamballerie, X., Boisson, V., Reynier, J.C. et al. (2008) On chikungunya acute infection and chloroquine treatment. Vector-borne and Zoonotic Diseases, 8, 837-839.
13. Delogu, I., and de Lamballerie, X. (2011) Chikungunya disease and chloroquine treatment. Journal of Medical Virology, 83, 1058-1059.
14. Delogu, I., Pastorino, B., Baronti, C. et al. (2011) In vitro antiviral activity of arbidol against chikungunya virus and characteristics of a selected resistant mutant. Antiviral Research, 90 (3), 99-107.
15. Enserink, M. (2007) Chikungunya: no longer a Third World disease. Science, 318, 1860-1861.
16. Eriksson, K.K., Cervantes-Barragán, L., Ludewig, B., and Thiel, V. (2008) Mouse hepatitis virus liver pathology is dependent on ADP-ribose-1′′-phosphatase, a viral function conserved in the alpha-like supergroup. Journal of Virology, 82 (24), 12825-12834.
17. Gay, B., Bernard, E., Solignat, M. et al. (2012) pH-dependent entry of chikungunya virus into Aedes albopictus cells. Infection, Genetics and Evolution, 12 (6), 1275-1281.
18. Girard-Valenciennes, E., Clerc, P., Grondin, I. et al. (2010) Medicinal plant potentialities from Reunion Island, in VIII International Symposium on Ethnobotany Disciplines, 3-8 October, Lisbon, Portugal.
19. Huang, L., Ho, P., Yu, J. et al. (2011) Picomolar dichotomous activity of gnidimacrin against HIV-1. PLOS ONE, 6, e26677.
20. Huang, S.Z., Zhang, X.J., Li, X.Y. et al. (2012) Daphnane-type diterpene esters with cytotoxic and anti-HIV activities from Daphne acutiloba Rehd. Phytochemistry, 75, 99-107.
21. Julander, J.G., Smee, D.F., Morrey, J.D., and Furuta, Y. (2009) Effect of T-705 treatment on western equine encephalitis in a mouse model. Antiviral Research, 82, 169-171.
22. Kaur, F., Thiruchelvan, M., Lee, R.C. et al. (2013) Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression. Antimicrobial Agents and Chemotherapy, 57, 155-167.
23. Khan, A.H., Morita, K., Parquet, M. et al. (2002) A Complete nucleotide sequence of Chikungunya Virus and evidence for an internal polyadenylation site. Journal of General Virology, 3075-3084.
24. Khan, M., Santhosh, S. R., Tiwari, M. et al. (2010) Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against chikungunya virus in Vero cells. Journal of Medical Virology, 82 (5), 817-824.
25. Khan, M., Dhanwani, R., Patro, I.K. et al. (2011) Cellular IMPDH enzyme activity is a potential target for the inhibition of chikungunya virus replication and virus induced apoptosis in cultured mammalian cells. Antiviral Research, 89, 1-8.
26. Koehn, F.E., and Carter, G.T. (2005) The evolving role of natural product in drug discovery. Nature Reviews Drug Discovery, 4, 206-220.
27. Leyssen, P., Litaudon, M., Guillemot, J.C. et al. (2011) PHYTOCHIK: biodiversity as a source of selective inhibitors of CHIKV replication. Antiviral Research, 90 (2), A36-A37.
28. Li, X.F., Jiang, T., Deng, Y. et al. (2012) Complete genome sequence of a chikungunya virus isolated in Guangdong, China. Antiviral Research, 86 (16), 8904-8905.
29. Lucas-Hourani, M., Lupan, A., Desprès, P. et al. (2013) A phenotopic assay to identify chikungunya virus inhibitors targeting the non structural protein nsP2. Journal of Biomolecular Screening, 18, 172-179.
30. Malet, H., Coutard, B., Jamal, S. et al. (2009) The crystal structures of chikungunya and Venezuelan equine encephalitis virus nsP3 macro domains define a conserved adenosine binding pocket. Journal of Virology, 83 (13), 6534-6545.
31. Newmann, D.J., and Cragg, G.M. (2012) Natural products as source of new drugs over the 30 years from 1981 to 2010. Journal of Natural Products, 75, 311-335.
32. Ogbomo, H., Michaelis, M., Altenbrandt, B. et al. (2010) A novel immunomodulatory mechanism of ribavirin in suppressing natural killer cell function. Biochemical Pharmacology, 79, 188-197.
33. Pialoux, G., Gauzere, B.A., Jaureguiberry, S., and Strobe, M. (2007) Chikungunya, an epidemic arbovirosis. Lancet Infectious Diseases, 7, 319-327.
34. Pohjala, L., Alakurtti, S., Ahola, T. et al. (2009) Betulin-derived compounds as inhibitors of alphavirus replication. Journal of Natural Products, 72, 1917-1926.
35. Pohjala, L., Utt, A., Varjak, M. et al. (2011) Inhibitors of alphavirus entry and replication identified with a stable chikungunya replicon cell line and virus-based assays. PLOS ONE, 6 (12), e28923.
36. Ravichandran, R., and Manian, M., 2008. Ribavirin therapy for chikungunya arthritis. Journal of Infection in Developing Countries, 2, 140-142.
37. Rubach, J.K., Wasik, B.R., Rupp, J.C. et al. (2009) Characterization of purified Sindbis virus nsP4 RNA-dependent RNA polymerase activity in vitro. Virology, 384 (1), 201-208.
38. Russo, A.T., White, M.A., and Watowich, S.J. (2006) The crystal structure of the Venezuelan equine encephalitis alphavirus nsP2 protease. Structure, 14 (9), 1449-1458.
39. Savarino, A., Boelaert, J.R., Cassone, A. et al. (2003) Effects of chloroquine on viral infections: an old drug against today's diseases. Lancet Infectious Diseases, 3 (11), 722-727.
40. Scheidel, LM., and Stollar, V. (1991) Mutations that confer resistance to mycophenolic acid and ribavirin on Sindbis virus map to the nonstructural protein nsP1. Virology, 181, 490-499.
41. Shi, L., Xiong, H., He, J., et al. (2007) Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo. Archives of Virology, 152, 1447-1455.
42. Vidal, V., Potterat, O., Louvel, S. et al. (2012) Library-based discovery and characterization of daphnane diterpenes as potent and selective HIV inhibitors in Daphne gnidium. Journal of Natural Products, 75, 414-419.
43. Zhang, L., Luo, R.H., Wang, F. et al. (2010) Daphnane diterpenoids isolated from Trigonostemon thyrsoideum as HIV-1 antivirals. Phytochemistry, 71, 1979-1883.